125 related articles for article (PubMed ID: 16735014)
1. [Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease].
Llor C; Naberan K; Cots JM; Molina J; Ros F; Miravitlles M;
Arch Bronconeumol; 2006 Apr; 42(4):175-82. PubMed ID: 16735014
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD.
Miravitlles M; Murio C; Guerrero T; Gisbert R;
Chest; 2002 May; 121(5):1449-55. PubMed ID: 12006427
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacoeconomic study of antibiotic therapy for exacerbations of chronic bronchitis and chronic obstructive pulmonary disease in Latin America].
Miravitlles M; Jardim JR; Zitto T; Rodrigues JE; López H
Arch Bronconeumol; 2003 Dec; 39(12):549-53. PubMed ID: 14636491
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.
Llor C; Naberan K; Cots JM; Molina J; Miravitlles M
Int J Clin Pract; 2004 Oct; 58(10):937-44. PubMed ID: 15587773
[TBL] [Abstract][Full Text] [Related]
5. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
[TBL] [Abstract][Full Text] [Related]
6. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
7. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
[TBL] [Abstract][Full Text] [Related]
8. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
Anzueto A; Miravitlles M; Ewig S; Legnani D; Heldner S; Stauch K
Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710
[TBL] [Abstract][Full Text] [Related]
9. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Chong J; Cates CJ
Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
[TBL] [Abstract][Full Text] [Related]
10. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease.
Miravitlles M; García-Polo C; Domenech A; Villegas G; Conget F; de la Roza C
Lung; 2013 Oct; 191(5):523-30. PubMed ID: 23842641
[TBL] [Abstract][Full Text] [Related]
12. [Direct costs to primary care of chronic bronchitis. Analysis of a prospective study].
Grupo DAFNE
Aten Primaria; 2001 Apr; 27(6):388-94. PubMed ID: 11334575
[TBL] [Abstract][Full Text] [Related]
13. Cost-effective therapy for acute exacerbations of chronic bronchitis.
Grossman RF
Semin Respir Infect; 2000 Mar; 15(1):71-81. PubMed ID: 10749552
[TBL] [Abstract][Full Text] [Related]
14. Acute exacerbations of chronic bronchitis: a pharmacoeconomic review of antibacterial use.
Morris S; Anderson P; Irwin DE
Pharmacoeconomics; 2002; 20(3):153-68. PubMed ID: 11929346
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
16. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Chodosh S; DeAbate CA; Haverstock D; Aneiro L; Church D
Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475
[TBL] [Abstract][Full Text] [Related]
17. Is co-morbidity taken into account in the antibiotic management of elderly patients with acute bronchitis and COPD exacerbations?
Bont J; Hak E; Birkhoff CE; Hoes AW; Verheij TJ
Fam Pract; 2007 Sep; 24(4):317-22. PubMed ID: 17602175
[TBL] [Abstract][Full Text] [Related]
18. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
19. Treatment cost of acute exacerbations of chronic bronchitis.
Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
Clin Ther; 1999 Mar; 21(3):576-91. PubMed ID: 10321424
[TBL] [Abstract][Full Text] [Related]
20. Costs of chronic bronchitis and COPD: a 1-year follow-up study.
Miravitlles M; Murio C; Guerrero T; Gisbert R
Chest; 2003 Mar; 123(3):784-91. PubMed ID: 12628879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
